DiscoverConversations in Drug DevelopmentExploring Genome Editing Technologies in Drug Development
Exploring Genome Editing Technologies in Drug Development

Exploring Genome Editing Technologies in Drug Development

Update: 2024-06-19
Share

Description

In this episode, host Dr. Katherine Bowen, is joined by Harriet Edwards, Associate Director in Regulatory Affairs, to explore the fascinating world of genome editing technologies. Together, they delve into the ethical considerations of editing somatic versus germline cells and trace the historical progression of these technologies from agriculture to healthcare. Join us as we discuss the complexity of genome editing methods, the irreversible nature of genetic changes, and the associated risks.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Exploring Genome Editing Technologies in Drug Development

Exploring Genome Editing Technologies in Drug Development

Boyds